↓ Skip to main content

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval

Overview of attention for article published in JAMA: Journal of the American Medical Association, May 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
201 news outlets
blogs
5 blogs
twitter
644 X users
facebook
1 Facebook page
reddit
1 Redditor

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
Published in
JAMA: Journal of the American Medical Association, May 2024
DOI 10.1001/jama.2024.2396
Pubmed ID
Authors

Ian T. T. Liu, Aaron S. Kesselheim, Edward R. Scheffer Cliff

X Demographics

X Demographics

The data shown below were collected from the profiles of 644 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 27%
Researcher 6 27%
Unspecified 3 14%
Professor 2 9%
Student > Postgraduate 1 5%
Other 2 9%
Unknown 2 9%
Readers by discipline Count As %
Medicine and Dentistry 7 32%
Biochemistry, Genetics and Molecular Biology 3 14%
Unspecified 3 14%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Nursing and Health Professions 1 5%
Other 4 18%
Unknown 2 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1857. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2024.
All research outputs
#5,449
of 25,956,379 outputs
Outputs from JAMA: Journal of the American Medical Association
#166
of 36,999 outputs
Outputs of similar age
#46
of 195,415 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#3
of 405 outputs
Altmetric has tracked 25,956,379 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,999 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,415 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 405 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.